{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T05:03:44Z","timestamp":1792904624254,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Science Foundation","award":["1563159"],"award-info":[{"award-number":["1563159"]}]},{"DOI":"10.13039\/100008072","name":"Gladstone Institutes","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008072","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"crossref","award":["5T32DK007007"],"award-info":[{"award-number":["5T32DK007007"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Chan Zuckerberg Biohub"},{"DOI":"10.13039\/100009576","name":"Kenneth Rainin Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009576","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009576","name":"Kenneth Rainin Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009576","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"crossref","award":["5T32DK007007"],"award-info":[{"award-number":["5T32DK007007"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Science Foundation","award":["1563159"],"award-info":[{"award-number":["1563159"]}]},{"DOI":"10.13039\/100008072","name":"Gladstone Institutes","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008072","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Chan Zuckerberg Biohub"},{"DOI":"10.13039\/100009576","name":"Kenneth Rainin Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009576","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Fecal microbiota transplant is a promising therapy for ulcerative colitis. Parameters maximizing effectiveness and tolerability are not yet clear, and it is not known how import the transmission of donor microbes to patients is. Here (clinicaltrails.gov: NCT03006809) we have tested the effects of antibiotic pretreatment and compared two modes of maintenance dose delivery, capsules versus enema, in a randomized, pilot, open-label, 2\u2009\u00d7\u20092 factorial design with 22 patients analyzed with mild to moderate UC. Clinically, the treatment was well-tolerated with favorable safety profile. Of patients who received antibiotic pretreatment, 6 of 11 experienced remission after 6 weeks of treatment, versus 2 of 11 non-pretreated patients (log\u00a0odds ratio: 1.69, 95% confidence interval: \u22120.25 to 3.62). No significant differences were found between maintenance dosing via capsules versus enema. In exploratory analyses, microbiome turnover at both the species and strain levels was extensive and significantly more pronounced in the pretreated patients. Associations were also revealed between taxonomic turnover and changes in the composition of primary and secondary bile acids. Together these findings suggest that antibiotic pretreatment contributes to microbiome engraftment and possibly clinical effectiveness, and validate longitudinal strain tracking as a powerful way to monitor the dynamics and impact of microbiota transfer.<\/jats:p>","DOI":"10.1038\/s41598-022-09307-5","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T06:21:23Z","timestamp":1648794083000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Strain-resolved analysis in a randomized trial of antibiotic pretreatment and maintenance dose delivery mode with fecal microbiota transplant for ulcerative colitis"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0182-404X","authenticated-orcid":false,"given":"Byron J.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvette","family":"Piceno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Zydek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara Aboud","family":"Syriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P.","family":"Terdiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zain","family":"Kassam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4817-1258","authenticated-orcid":false,"given":"Averil","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5695-7336","authenticated-orcid":false,"given":"Susan V.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine S.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najwa","family":"El-Nachef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,1]]},"reference":[{"key":"9307_CR1","doi-asserted-by":"crossref","first-page":"175628481989103","DOI":"10.1177\/1756284819891038","volume":"12","author":"M Yalchin","year":"2019","unstructured":"Yalchin, M. et al. Gaps in knowledge and future directions for the use of faecal microbiota transplant in the treatment of inflammatory bowel disease. Ther. Adv. Gastroenterol. 12, 1756284819891038 (2019).","journal-title":"Ther. Adv. Gastroenterol."},{"key":"9307_CR2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/14712598.2020.1733964","volume":"20","author":"LR Lopetuso","year":"2020","unstructured":"Lopetuso, L. R. et al. Fecal transplantation for ulcerative colitis: Current evidence and future applications. Expert Opin. Biol. Ther. 20, 343\u2013351 (2020).","journal-title":"Expert Opin. Biol. Ther."},{"key":"9307_CR3","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/ecco-jcc\/jjx063","volume":"11","author":"S Paramsothy","year":"2017","unstructured":"Paramsothy, S. et al. Faecal microbiota transplantation for inflammatory bowel disease: A systematic review and meta-analysis. J. Crohns Colitis 11, 1180\u20131199 (2017).","journal-title":"J. Crohns Colitis"},{"key":"9307_CR4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/apt.14173","volume":"46","author":"SP Costello","year":"2017","unstructured":"Costello, S. P. et al. Systematic review with meta-analysis: Faecal microbiota transplantation for the induction of remission for active ulcerative colitis. Aliment. Pharmacol. Ther. 46, 213\u2013224 (2017).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"9307_CR5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1089\/crispr.2018.0046","volume":"2","author":"TJ Lam","year":"2019","unstructured":"Lam, T. J. & Ye, Y. CRISPRs for strain tracking and their application to microbiota transplantation data analysis. CRISPR J. 2, 41\u201350 (2019).","journal-title":"CRISPR J."},{"key":"9307_CR6","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3390\/jcm10050959","volume":"10","author":"V Mocanu","year":"2021","unstructured":"Mocanu, V. et al. Repeated fecal microbial transplantations and antibiotic pre-treatment are linked to improved clinical response and remission in inflammatory bowel disease: A systematic review and pooled proportion meta-analysis. J. Clin. Med. 10, 959 (2021).","journal-title":"J. Clin. Med."},{"key":"9307_CR7","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2015.03.045","volume":"149","author":"NG Rossen","year":"2015","unstructured":"Rossen, N. G. et al. Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis. Gastroenterology 149, 110\u2013118 (2015).","journal-title":"Gastroenterology"},{"key":"9307_CR8","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.gastro.2015.04.001","volume":"149","author":"P Moayyedi","year":"2015","unstructured":"Moayyedi, P. et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology 149, 102\u2013109 (2015).","journal-title":"Gastroenterology"},{"key":"9307_CR9","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S0140-6736(17)30182-4","volume":"389","author":"S Paramsothy","year":"2017","unstructured":"Paramsothy, S. et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: A randomised placebo-controlled trial. Lancet 389, 1218\u20131228 (2017).","journal-title":"Lancet"},{"key":"9307_CR10","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jama.2018.20046","volume":"321","author":"SP Costello","year":"2019","unstructured":"Costello, S. P. et al. Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: A randomized clinical trial. JAMA 321, 156\u2013164 (2019).","journal-title":"JAMA"},{"key":"9307_CR11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrgastro.2017.88","volume":"14","author":"J Ni","year":"2017","unstructured":"Ni, J., Wu, G. D., Albenberg, L. & Tomov, V. T. Gut microbiota and IBD: Causation or correlation?. Nat. Rev. Gastroenterol. Hepatol. 14, 573\u2013584 (2017).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"9307_CR12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/pathogens8030126","volume":"8","author":"I Khan","year":"2019","unstructured":"Khan, I. et al. Alteration of Gut microbiota in inflammatory bowel disease (IBD): Cause or consequence? IBD treatment targeting the Gut microbiome. Pathogens 8, 126 (2019).","journal-title":"Pathogens"},{"key":"9307_CR13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/MIB.0000000000000975","volume":"23","author":"D Ishikawa","year":"2017","unstructured":"Ishikawa, D. et al. Changes in intestinal microbiota following combination therapy with fecal microbial transplantation and antibiotics for ulcerative colitis. Inflamm. Bowel Dis. 23, 116\u2013125 (2017).","journal-title":"Inflamm. Bowel Dis."},{"key":"9307_CR14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/apt.14387","volume":"47","author":"P Kump","year":"2018","unstructured":"Kump, P. et al. The taxonomic composition of the donor intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in therapy refractory ulcerative colitis. Aliment. Pharmacol. Ther. 47, 67\u201377 (2018).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"9307_CR15","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/jama.2017.17077","volume":"318","author":"D Kao","year":"2017","unstructured":"Kao, D. et al. Effect of oral capsule vs colonoscopy-delivered fecal microbiota transplantation on recurrent Clostridium difficile infection: A randomized clinical trial. JAMA - J. Am. Med. Assoc. 318, 1985\u20131993 (2017).","journal-title":"JAMA - J. Am. Med. Assoc."},{"key":"9307_CR16","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1007\/s10620-019-05596-5","volume":"64","author":"E Adler","year":"2019","unstructured":"Adler, E. et al. Capsule-delivered fecal microbiota transplant is safe and well tolerated in patients with ulcerative colitis. Dig. Dis. Sci. 64, 2452\u20132454 (2019).","journal-title":"Dig. Dis. Sci."},{"key":"9307_CR17","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-62372\/v1","author":"J Crothers","year":"2020","unstructured":"Crothers, J. et al. Daily, oral FMT for long-term maintenance therapy in ulcerative colitis: Results of a single-center, prospective, randomized pilot study. BMC Gasteroentrol. https:\/\/doi.org\/10.21203\/rs.3.rs-62372\/v1 (2020).","journal-title":"BMC Gasteroentrol."},{"key":"9307_CR18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/00365521.2019.1585939","volume":"54","author":"F Cold","year":"2019","unstructured":"Cold, F. et al. Multidonor FMT capsules improve symptoms and decrease fecal calprotectin in ulcerative colitis patients while treated an open-label pilot study. Scand. J. Gastroenterol. 54, 289\u2013296 (2019).","journal-title":"Scand. J. Gastroenterol."},{"key":"9307_CR19","first-page":"4","volume":"2019","author":"TJ Borody","year":"2019","unstructured":"Borody, T. J. & Clancy, A. Fecal microbiota transplantation for ulcerative colitiswhere to from here?. Transl. Gastroenterol. Hepatol. 2019, 4 (2019).","journal-title":"Transl. Gastroenterol. Hepatol."},{"key":"9307_CR20","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.3390\/jcm9061757","volume":"9","author":"S Bibb\u00f2","year":"2020","unstructured":"Bibb\u00f2, S. et al. Fecal microbiota transplantation: Screening and selection to choose the optimal donor. J. Clin. Med. 9, 1757 (2020).","journal-title":"J. Clin. Med."},{"key":"9307_CR21","doi-asserted-by":"crossref","first-page":"100026","DOI":"10.1016\/j.medmic.2020.100026","volume":"6","author":"A Singh","year":"2020","unstructured":"Singh, A., Mahajan, R., Kao, D., Midha, V. & Sood, A. Long term management of ulcerative colitis with faecal microbiota transplantation. Med. Microecol. 6, 100026 (2020).","journal-title":"Med. Microecol."},{"key":"9307_CR22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.chom.2018.01.003","volume":"23","author":"CS Smillie","year":"2018","unstructured":"Smillie, C. S. et al. Strain tracking reveals the determinants of bacterial engraftment in the human gut following fecal microbiota transplantation. Cell Host Microbe 23, 229-240.e5 (2018).","journal-title":"Cell Host Microbe"},{"key":"9307_CR23","doi-asserted-by":"crossref","unstructured":"Chu, N. D. et al. Dynamic colonization of microbes and their functions after fecal microbiota transplantation for inflammatory bowel disease. mBio. https:\/\/doi.org\/10.1128\/mBio.00975-21 (2021).","DOI":"10.1128\/mBio.00975-21"},{"key":"9307_CR24","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nmeth.1650","volume":"8","author":"D Knights","year":"2011","unstructured":"Knights, D. et al. Bayesian community-wide culture-independent microbial source tracking. Nat. Methods 8, 761\u2013763 (2011).","journal-title":"Nat. Methods"},{"key":"9307_CR25","doi-asserted-by":"crossref","first-page":"e8783","DOI":"10.7717\/peerj.8783","volume":"8","author":"JJ McGhee","year":"2020","unstructured":"McGhee, J. J. et al. Meta-SourceTracker: Application of Bayesian source tracking to shotgun metagenomics. PeerJ 8, e8783 (2020).","journal-title":"PeerJ"},{"key":"9307_CR26","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.1038\/s41467-019-13036-1","volume":"10","author":"JS Johnson","year":"2019","unstructured":"Johnson, J. S. et al. Evaluation of 16S rRNA gene sequencing for species and strain-level microbiome analysis. Nat. Commun. 10, 5029 (2019).","journal-title":"Nat. Commun."},{"key":"9307_CR27","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1053\/j.gastro.2018.12.001","volume":"156","author":"S Paramsothy","year":"2019","unstructured":"Paramsothy, S. et al. Specific bacteria and metabolites associated with response to fecal microbiota transplantation in patients with ulcerative colitis. Gastroenterology 156, 1440-1454.e2 (2019).","journal-title":"Gastroenterology"},{"key":"9307_CR28","doi-asserted-by":"crossref","first-page":"e115175","DOI":"10.1371\/journal.pone.0115175","volume":"9","author":"A Labb\u00e9","year":"2014","unstructured":"Labb\u00e9, A., Ganopolsky, J. G., Martoni, C. J., Prakash, S. & Jones, M. L. Bacterial bile metabolising gene abundance in Crohn\u2019s, ulcerative colitis and type 2 diabetes metagenomes. PLoS ONE 9, e115175 (2014).","journal-title":"PLoS ONE"},{"key":"9307_CR29","first-page":"266","volume":"31","author":"E Tiratterra","year":"2018","unstructured":"Tiratterra, E. et al. Role of bile acids in inflammatory bowel disease. Ann. Gastroenterol. 31, 266\u2013272 (2018).","journal-title":"Ann. Gastroenterol."},{"key":"9307_CR30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s40168-019-0689-3","volume":"7","author":"A Heinken","year":"2019","unstructured":"Heinken, A. et al. Systematic assessment of secondary bile acid metabolism in gut microbes reveals distinct metabolic capabilities in inflammatory bowel disease. Microbiome 7, 75 (2019).","journal-title":"Microbiome"},{"key":"9307_CR31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/CEG.S186097","volume":"12","author":"BP Vaughn","year":"2019","unstructured":"Vaughn, B. P. et al. A pilot study of fecal bile acid and microbiota profiles in inflammatory bowel disease and primary sclerosing cholangitis. Clin. Exp. Gastroenterol. 12, 9\u201319 (2019).","journal-title":"Clin. Exp. Gastroenterol."},{"key":"9307_CR32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","volume":"17","author":"A Lavelle","year":"2020","unstructured":"Lavelle, A. & Sokol, H. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Nat. Rev. Gastroenterol. Hepatol. 17, 223\u2013237 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"9307_CR33","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.chom.2020.01.021","volume":"27","author":"SR Sinha","year":"2020","unstructured":"Sinha, S. R. et al. Dysbiosis-induced secondary bile acid deficiency promotes intestinal inflammation. Cell Host Microbe 27, 659-670.e5 (2020).","journal-title":"Cell Host Microbe"},{"key":"9307_CR34","doi-asserted-by":"crossref","first-page":"175628482110180","DOI":"10.1177\/17562848211018098","volume":"14","author":"R Sun","year":"2021","unstructured":"Sun, R., Xu, C., Feng, B., Gao, X. & Liu, Z. Critical roles of bile acids in regulating intestinal mucosal immune responses. Ther. Adv. Gastroenterol. 14, 17562848211018098 (2021).","journal-title":"Ther. Adv. Gastroenterol."},{"key":"9307_CR35","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s10620-020-06715-3","volume":"66","author":"S Fiorucci","year":"2021","unstructured":"Fiorucci, S. et al. Bile acid signaling in inflammatory bowel diseases. Dig. Dis. Sci. 66, 674\u2013693 (2021).","journal-title":"Dig. Dis. Sci."},{"key":"9307_CR36","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.3748\/wjg.v27.i24.3609","volume":"27","author":"Z-H Yang","year":"2021","unstructured":"Yang, Z.-H. et al. Altered profiles of fecal bile acids correlate with gut microbiota and inflammatory responses in patients with ulcerative colitis. World J. Gastroenterol. 27, 3609\u20133629 (2021).","journal-title":"World J. Gastroenterol."},{"key":"9307_CR37","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","volume":"317","author":"KW Schroeder","year":"1987","unstructured":"Schroeder, K. W., Tremaine, W. J. & Ilstrup, D. M. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. N. Engl. J. Med. 317, 1625\u20131629 (1987).","journal-title":"N. Engl. J. Med."},{"key":"9307_CR38","doi-asserted-by":"publisher","unstructured":"Shi, Z. J., Dimitrov, B., Zhao, C., Nayfach, S. & Pollard, K. S. Ultra-rapid metagenotyping of the human gut microbiome. bioRxiv 2020.06.12.149336. https:\/\/doi.org\/10.1101\/2020.06.12.149336 (2020).","DOI":"10.1101\/2020.06.12.149336"},{"key":"9307_CR39","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13293-019-0265-3","volume":"10","author":"T Phelps","year":"2019","unstructured":"Phelps, T., Snyder, E., Rodriguez, E., Child, H. & Harvey, P. The influence of biological sex and sex hormones on bile acid synthesis and cholesterol homeostasis. Biol. Sex Differ. 10, 52 (2019).","journal-title":"Biol. Sex Differ."},{"key":"9307_CR40","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/nbt.4229","volume":"36","author":"DH Parks","year":"2018","unstructured":"Parks, D. H. et al. A standardized bacterial taxonomy based on genome phylogeny substantially revises the tree of life. Nat. Biotechnol. 36, 996\u20131004 (2018).","journal-title":"Nat. Biotechnol."},{"key":"9307_CR41","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/s41587-020-0501-8","volume":"38","author":"DH Parks","year":"2020","unstructured":"Parks, D. H. et al. A complete domain-to-species taxonomy for bacteria and archaea. Nat. Biotechnol. 38, 1079\u20131086 (2020).","journal-title":"Nat. Biotechnol."},{"key":"9307_CR42","doi-asserted-by":"crossref","first-page":"15683","DOI":"10.1038\/s41598-019-51878-3","volume":"9","author":"H Earley","year":"2019","unstructured":"Earley, H. et al. The abundance of Akkermansia muciniphila and its relationship with sulphated colonic mucins in health and ulcerative colitis. Sci. Rep. 9, 15683 (2019).","journal-title":"Sci. Rep."},{"key":"9307_CR43","doi-asserted-by":"crossref","unstructured":"Bian, X. et al. Administration of Akkermansia muciniphila ameliorates dextran sulfate sodium-induced ulcerative colitis in mice. Front. Microbiol. (2019).","DOI":"10.3389\/fmicb.2019.02259"},{"key":"9307_CR44","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1126\/science.aad8852","volume":"352","author":"SS Li","year":"2016","unstructured":"Li, S. S. et al. Durable coexistence of donor and recipient strains after fecal microbiota transplantation. Science 352, 586\u2013589 (2016).","journal-title":"Science"},{"key":"9307_CR45","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.csbj.2019.07.012","volume":"17","author":"M Vital","year":"2019","unstructured":"Vital, M., Rud, T., Rath, S., Pieper, D. H. & Schl\u00fcter, D. Diversity of bacteria exhibiting bile acid-inducible 7 \u03b1-dehydroxylation genes in the human gut. Comput. Struct. Biotechnol. J. 17, 1016\u20131019 (2019).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"9307_CR46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40168-019-0628-3","volume":"7","author":"Z Song","year":"2019","unstructured":"Song, Z. et al. Taxonomic profiling and populational patterns of bacterial bile salt hydrolase (BSH) genes based on worldwide human gut microbiome. Microbiome 7, 9 (2019).","journal-title":"Microbiome"},{"key":"9307_CR47","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1001\/jama.2017.17969","volume":"318","author":"K Rao","year":"2017","unstructured":"Rao, K., Young, V. B. & Malani, P. N. Capsules for fecal microbiota transplantation in recurrent Clostridium difficile infection: The new way forward or a tough pill to swallow?. JAMA 318, 1979\u20131980 (2017).","journal-title":"JAMA"},{"key":"9307_CR48","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fcimb.2019.00002","volume":"9","author":"BC Wilson","year":"2019","unstructured":"Wilson, B. C., Vatanen, T., Cutfield, W. S. & O\u2019Sullivan, J. M. The super-donor phenomenon in fecal microbiota transplantation. Front. Cell. Infect. Microbiol. 9, 2 (2019).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"9307_CR49","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1053\/j.gastro.2019.11.294","volume":"158","author":"R Pittayanon","year":"2020","unstructured":"Pittayanon, R. et al. Differences in Gut microbiota in patients with vs without inflammatory bowel diseases: A systematic review. Gastroenterology 158, 930-946.e1 (2020).","journal-title":"Gastroenterology"},{"key":"9307_CR50","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.3389\/fmicb.2020.01925","volume":"11","author":"C Anyansi","year":"2020","unstructured":"Anyansi, C., Straub, T. J., Manson, A. L., Earl, A. M. & Abeel, T. Computational methods for strain-level microbial detection in colony and metagenome sequencing data. Front. Microbiol. 11, 1925 (2020).","journal-title":"Front. Microbiol."},{"key":"9307_CR51","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1038\/s41467-017-02209-5","volume":"8","author":"D Albanese","year":"2017","unstructured":"Albanese, D. & Donati, C. Strain profiling and epidemiology of bacterial species from metagenomic sequencing. Nat. Commun. 8, 2260 (2017).","journal-title":"Nat. Commun."},{"key":"9307_CR52","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1101\/gr.216242.116","volume":"27","author":"DT Truong","year":"2017","unstructured":"Truong, D. T., Tett, A., Pasolli, E., Huttenhower, C. & Segata, N. Microbial strain-level population structure and genetic diversity from metagenomes. Genome Res. 27, 626\u2013638 (2017).","journal-title":"Genome Res."},{"key":"9307_CR53","doi-asserted-by":"publisher","unstructured":"Podlesny, D. & Fricke, W. F. Microbial Strain Engraftment, Persistence and Replacement After Fecal Microbiota Transplantation. medRxiv 2020.09.29.20203638. https:\/\/doi.org\/10.1101\/2020.09.29.20203638 (2020).","DOI":"10.1101\/2020.09.29.20203638"},{"key":"9307_CR54","doi-asserted-by":"crossref","first-page":"S574","DOI":"10.14309\/00000434-201810001-01017","volume":"113","author":"JR Allegretti","year":"2018","unstructured":"Allegretti, J. R. et al. Bile acid profiles are not altered by fecal microbiota transplantation for the treatment of primary sclerosing cholangitis: Category award (liver): presidential poster award: 1017. Off. J. Am. Coll. Gastroenterol. ACG 113, S574 (2018).","journal-title":"Off. J. Am. Coll. Gastroenterol. ACG"},{"key":"9307_CR55","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1913670","author":"Z Kassam","year":"2019","unstructured":"Kassam, Z. et al. Donor screening for fecal microbiota transplantation. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMc1913670 (2019).","journal-title":"N. Engl. J. Med."},{"key":"9307_CR56","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00004836-198708000-00011","volume":"9","author":"T Gilat","year":"1987","unstructured":"Gilat, T. et al. A comparative study of metronidazole and sulfasalazine in active, not severe, ulcerative colitis. An Israeli multicenter trial. J. Clin. Gastroenterol. 9, 415\u2013417 (1987).","journal-title":"J. Clin. Gastroenterol."},{"key":"9307_CR57","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1136\/gut.27.10.1210","volume":"27","author":"RW Chapman","year":"1986","unstructured":"Chapman, R. W., Selby, W. S. & Jewell, D. P. Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis. Gut 27, 1210\u20131212 (1986).","journal-title":"Gut"},{"key":"9307_CR58","first-page":"454","volume":"92","author":"GJ Mantzaris","year":"1997","unstructured":"Mantzaris, G. J. et al. A prospective randomized controlled trial of oral ciprofloxacin in acute ulcerative colitis. Am. J. Gastroenterol. 92, 454\u2013456 (1997).","journal-title":"Am. J. Gastroenterol."},{"key":"9307_CR59","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1080\/003655201750305503","volume":"36","author":"GJ Mantzaris","year":"2001","unstructured":"Mantzaris, G. J. et al. A prospective randomized controlled trial of intravenous ciprofloxacin as an adjunct to corticosteroids in acute, severe ulcerative colitis. Scand. J. Gastroenterol. 36, 971\u2013974 (2001).","journal-title":"Scand. J. Gastroenterol."},{"key":"9307_CR60","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1093\/bioinformatics\/bts480","volume":"28","author":"J K\u00f6ster","year":"2012","unstructured":"K\u00f6ster, J. & Rahmann, S. Snakemakea scalable bioinformatics workflow engine. Bioinformatics 28, 2520\u20132522 (2012).","journal-title":"Bioinformatics"},{"key":"9307_CR61","first-page":"2","volume":"2","author":"D Merkel","year":"2014","unstructured":"Merkel, D. Docker: Lightweight Linux containers for consistent development and deployment. Linux J. 2, 2 (2014).","journal-title":"Linux J."},{"key":"9307_CR62","unstructured":"Anaconda Software Distribution. (Anaconda Inc., 2020)."},{"key":"9307_CR63","doi-asserted-by":"publisher","unstructured":"Kluyver, T. et al. Jupyter notebooks a publishing format for reproducible computational workflows. in Positioning and Power in Academic Publishing: Players, Agents and Agendas (eds. Loizides, F. & Scmidt, B.). 87\u201390. https:\/\/doi.org\/10.3233\/978-1-61499-649-1-87 (IOS Press, 2016).","DOI":"10.3233\/978-1-61499-649-1-87"},{"key":"9307_CR64","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41587-020-0603-3","volume":"39","author":"A Almeida","year":"2021","unstructured":"Almeida, A. et al. A unified catalog of 204,938 reference genomes from the human gut microbiome. Nat Biotechnol 39, 105\u2013114 (2021).","journal-title":"Nat Biotechnol"},{"key":"9307_CR65","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa, F. et al. Scikit-learn: Machine learning in Python. J. Mach. Learn. Res. 12, 2825\u20132830 (2011).","journal-title":"J. Mach. Learn. Res."},{"key":"9307_CR66","first-page":"1","volume":"15","author":"S H\u00f8jsgaard","year":"2005","unstructured":"H\u00f8jsgaard, S., Halekoh, U. & Yan, J. The R package geepack for generalized estimating equations. J. Stat. Softw. 15, 1\u201311 (2005).","journal-title":"J. Stat. Softw."},{"key":"9307_CR67","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/2041-210x.12018","volume":"4","author":"G Guillot","year":"2013","unstructured":"Guillot, G. & Rousset, F. Dismantling the Mantel tests. Methods Ecol. Evol. 4, 336\u2013344 (2013).","journal-title":"Methods Ecol. Evol."},{"key":"9307_CR68","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","volume":"569","author":"J Lloyd-Price","year":"2019","unstructured":"Lloyd-Price, J. et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature 569, 655\u2013662 (2019).","journal-title":"Nature"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09307-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09307-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09307-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T20:05:07Z","timestamp":1669320307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09307-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["9307"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-09307-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.08.07.21261556","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,1]]},"assertion":[{"value":"2 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"YMP is an employee of Symbiome, Inc. ZK is an employee\/shareholder at Finch Therapeutics. SVL is co-founder and shareholder of Siolta Therapeutics, Inc.\u00a0and serves as both a consultant and a member of its Board of Directors. KSP is on the scientific advisory board of Phylagen. NE has received research support from Finch Therapeutics and Assembly Biosciences, and has been a consultant for Federation Bio and Ferring Pharmaceuticals. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5517"}}